STOCK MARKET BSE NSE

Genome Editing Tool Could Alter Human Stem Cells

For the new study, Cheng and the team pitted CRISPR against TALEN in human iPSCs, adult cells re-programmed to act like embryonic stem cells.

Published: 06th January 2015 01:00 PM  |   Last Updated: 06th January 2015 01:00 PM   |  A+A-

stemcells_b

Mouse embryonic stem cells with fluorescent marker. (Image courtesy to WikiMedia Commons)

By IANS

WASHINGTON: Scientists at the Johns Hopkins University in the US have shown that a powerful "genome editing" technology known as CRISPR can alter human stem cells precisely and efficiently.
The findings could speed efforts to modify human-induced pluripotent stem cells (iPSCs) for use as treatments or in the development of model systems to study diseases and test drugs.
"Stem cell technology is quickly advancing and we think that the days when we can use iPSCs for human therapy aren't that far away," said Zhaohui Ye from the Johns Hopkins University's School of Medicine.
CRISPR has been used by researchers since 2012 to trim, disrupt, replace or add to sequences of an organism's DNA.
Previous research has shown that CRISPR can generate genomic changes or mutations through these interventions far more efficiently than other gene editing techniques such as TALEN (transcription activator-like effector nuclease).
For the new study, Cheng and the team pitted CRISPR against TALEN in human iPSCs, adult cells re-programmed to act like embryonic stem cells.
Human iPSCs have already shown enormous promise with regard to treating and studying disease.
The comparison found that CRISPR system was significantly more efficient than TALEN.
The researchers found that the CRISPR system has an advantage over TALEN: It can be designed to target only the mutation-containing gene without affecting the healthy gene in patients.
"CRISPR-mediated genome editing opens the door to many genetic applications in biologically relevant cells that can lead to better understanding of and potential cures for human diseases," added Linzhao Cheng, professor at the Johns Hopkins University.
The report appeared in the journal Molecular Therapy.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp